Cre is expressed from the mouse Drd1a promoter in this YAC transgenic strain (D1-Cre). The spatio-temporal pattern of Cre expression in dopaminoceptive neurons is reported to closely recapitulate that of the endogenous Drd1a gene in embryonic and adult stages.
Of note, D1-Cre YAC transgenic mice are available on 129S-congenic background (Stock No. 028298) and C57BL/6J-congenic background (Stock No. 030329).
Eric R Kandel, Columbia University
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Recombinase-expressing) |
Alterations in dopamine signaling are responsible for several psychomotor disorders.
These YAC transgenic mice express Cre recombinase from the mouse Drd1a (dopamine receptor D1) promoter. The spatio-temporal pattern of Cre expression in dopaminoceptive neurons is reported to closely recapitulate that of the endogenous Drd1a gene in embryonic and adult stages, as assessed by immunohistological approaches.
Expression is reported to be prominent in the major projection areas of the dopaminergic system, including the striatum, nucleus accumbens, olfactory tubercles and prefrontal cortex. Clear but lower expression is seen in layer VI of the cortex. In hippocampus, CA2 and scattered cells in the dentate gyrus express Cre. Several thalamic nuclei and the ventromedian hypothalamic nucleus also express Cre. In retina, robust staining is observed in the inner nuclear layer.
Cre begins to be expressed, albeit at low levels, at E16 in the striosomal neurons of the embryonic striatum.
A 140 kb YAC containing the entire Drd1a gene (as well as 40 kb of upstream and 100 kb of downstream sequences) was isolated from a mouse genomic YAC library. Nuclear-localized Cre (nlsCre) was introduced to the Drd1a gene by homologous recombination in yeast. The ATG of the nlsCre replaces the ATG of the Drd1a gene and the STOP codon of the nlsCre interrupts the Drd1a open reading frame after its last possible internal ATG. YAC DNA was microinjected into the pronucleus of FVB/N oocytes. The transgenic line was maintained by backcrossing to C57BL/6. This strain was backcrossed to 129S6SvEvTac for more than 10 generations by the donating laboratory. Founder line A carries three copies of the YAC transgene.
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
---|---|
Site of Expression | Cre is expressed in dopaminoceptive neurons. |
Allele Name | transgene insertion A, Gunther Schutz |
---|---|
Allele Type | Transgenic (Recombinase-expressing) |
Allele Synonym(s) | D1Cre; dr-1 Cre; Tg(Drd1a-cre)2Gsc |
Gene Symbol and Name | Tg(Drd1a-cre)AGsc, transgene insertion A, Gunther Schutz |
Gene Synonym(s) | |
Promoter | Drd1, dopamine receptor D1, mouse, laboratory |
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
Site of Expression | Cre is expressed in dopaminoceptive neurons. |
Strain of Origin | FVB/N |
Chromosome | UN |
General Note | % transgenic mouse lines were create (A, R, S, T and U). Lines T and U do not contain complete transgenes while the other three lines exhibit virtually identical expression patterns. Line A was choosen as the representative line. |
Molecular Note | A YAC containing the cre open reading frame with a nuclear localization signal and under the control of a Drd1a promoter was used to create a transgene. Expression was confirmed through crosses with three reporter lines and localized to the major dopaminoceptive regions. Line A contains 3 copies of the transgene. |
Mutations Made By | Guenther Schuetz (G¿nther Sch¿tz), German Cancer Research Center (DKFZ) |
Hemizygotes are viable and fertile.
When using the D1-Cre mouse strain in a publication, please cite the originating article(s) and include JAX stock #028298 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier for Tg(Drd1a-cre)AGsc |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.